To view or add a comment, sign in A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy without adding side effects in a mid-stage clinical trial, pointing to a powerful new combination approach to tackling obesity
Propafenone: Drug information
We are grateful to the Indian Knowledge System (IKS) Division, Ministry of Education (MoE), Government of India, for the financial support provided for this research work and fellowship for SR through project [F.2-23/AICTE/IKS-BGS1/ResearchProject/2022-23/24]
Mech Ageing Dev 128: 92-105
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity, PubMed.gov, Wissam Ghusn, Alan De la Rosa, Daniel Sacoto, Lizeth Cifuentes, Alejandro Campos, Fauzi Feris, Maria Daniela Hurtado, Andres Acosta